The global focus on gene and cell therapies has grown exponentially in recent years as more development programs have advanced to later stages or even approval. In this article published in Life Science Leader, the authors discuss the challenges for gene and cell therapy research and how new approaches to innovation and financing, such as platform diversification and partnering with academia, could help support development of cell and gene therapies. To access the article, click here.
The authors wish to acknowledge the contributions of Pascale Diesel, Stephanie Donahue, and Michael Krepps to this article.
Articles
Building new business models to support cell and gene therapy R&D
July 13, 2018
Key contacts
Upcoming events
Swiss Biotech Day 2026
CRA is a proud sponsor of the premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful...
Informa: EU Pharmaceutical Law Forum 2026
CRA is a proud sponsor the event featuring authority insights from the EU Commission, Competition Authorities, EMA and leading pharmaceutical...